Deals In Depth: May 2015

Sigma-Tau sold Baxter its leukemia drug Oncaspar for $900 million; CVS boosted its retail pharmacy business with Omnicare purchase. There was a strong showing of PIPEs in the $3 billion in biopharma financing.

Exhibit 1

Top Alliances In May 2015

More from Deal-Making

More from In Vivo